Understanding EMAtS (Doose Syndrome)
At a Glance
EMAtS, or Doose syndrome, is a rare childhood epilepsy marked by brief muscle jerks and sudden loss of muscle tone that can cause falls. Seizures may be intense at first, but many children improve with individualized medicines, a supervised ketogenic diet, and safety planning.
If your child was healthy and meeting every milestone until suddenly being overwhelmed by seizures, the world can feel like it has shifted under your feet. This experience—of a previously healthy child suddenly developing frequent, unpredictable seizures—is a common presentation of Epilepsy with Myoclonic-Atonic Seizures (EMAtS), formerly and still commonly known as Doose Syndrome.
EMAtS is a rare condition, accounting for approximately 1% to 2% of all childhood epilepsies [1][2]. It typically begins between the ages of 2 and 4, though onset can range from 6 months to 6 years [3][4]. For many parents, the diagnosis marks the beginning of a period characterized by intense medical appointments, new terminology, and a deep sense of uncertainty.
Defining EMAtS
The name of this syndrome describes its core feature: myoclonic-atonic seizures.
- Myoclonic: A sudden, brief muscle jerk.
- Atonic: A sudden loss of muscle tone, often causing the child to go limp.
When these happen together, they often result in drop attacks, where a child may suddenly fall to the ground [4][5].
While the seizures are the most visible part of the condition, EMAtS may be associated with learning or developmental difficulties, and is considered a developmental and epileptic encephalopathy. This means that both the frequent seizure activity and the underlying brain patterns can interfere with a child’s development [6].
Navigating the “Stormy Phase”
Many families describe a period of “seizure chaos” shortly after diagnosis. Clinicians often refer to this informally as the stormy phase [4]. This is a characteristic evolution of the syndrome where seizures become frequent, intense, and often resistant to the first few medications tried [7].
During this phase, you may observe:
- High Seizure Frequency: Children may experience dozens, or in severe cases, hundreds of brief seizures a day [8][9].
- Multiple Seizure Types: In addition to drop attacks, you may see generalized tonic-clonic seizures (convulsions), absences (staring spells), or prolonged states of confusion [1][3].
- Apparent Developmental Regression: Children may seem to “plateau” or lose previously mastered skills, such as speech or potty training [5]. It is vital to note that true developmental regression requires a prompt medical assessment. Apparent loss of skills can reflect ongoing seizures, medication side effects, sleep deprivation, or nonconvulsive status epilepticus—issues that your doctor can help evaluate and address.
The Emotional Impact on the Family
The sudden transition to managing a child with complex medical needs can cause what some experts call diagnostic trauma. Parents often experience:
- Hypervigilance: A constant, exhausting state of “waiting for the next fall,” which often leads to severe sleep deprivation for the whole family [10][11].
- Grief: Mourning the life you imagined for your child while simultaneously managing their new needs [12].
- Social Isolation: The difficulty of taking a child who may have a “drop attack” at any moment into public spaces can lead families to withdraw from social activities [12].
Treatment and the Path Forward
While the “stormy phase” is grueling, there is significant cause for hope. Research shows that over 60% of children with EMAtS in some cohorts eventually achieve complete seizure freedom [1][5].
Current management strategies emphasize:
- Careful Medication Selection: Some common epilepsy drugs (like levetiracetam) can actually worsen seizures in some children with EMAtS [13][1]. Your doctor will carefully choose and monitor medications like valproate, clobazam, or ethosuximide [7].
- Early Ketogenic Diet Consideration: The ketogenic diet (a medical diet supervised by specialists) has strong observational evidence in EMAtS. Experts frequently consider this diet early in treatment rather than waiting for multiple medications to fail [5][14].
- Safety Planning: Because of the risk of injury from falls, children may wear specialized helmets, guided by their medical team [15].
The road to stability in EMAtS can be long, but the majority of children do eventually find a path to better seizure control [1].
Common questions in this guide
What is EMAtS, also called Doose syndrome?
What does the stormy phase of Doose syndrome mean?
Can children with EMAtS eventually become seizure-free?
When might a ketogenic diet be considered for EMAtS?
Which medicines are commonly considered, and can any worsen seizures?
How can we protect a child from injuries caused by drop attacks?
What should I do if my child seems to lose developmental skills?
Questions For You
Answer a question to get research tailored to you. Your answers are private.
Get notified when new evidence is published on Epilepsy with myoclonic-atonic seizures.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.What is my child's current seizure burden, and are we in what is considered a 'stormy phase'?
- 2.Has my child's EEG shown any signs of nonconvulsive status epilepticus (NCSE), and what symptoms should I look for?
- 3.How does my child's early developmental history and EEG background impact their long-term outlook?
- 4.At what point should we consider starting the ketogenic diet, and can we meet with a metabolic dietitian now?
- 5.Which medications should we avoid because they might make my child's specific seizure types worse?
- 6.Can we create a written Seizure Action Plan that includes instructions for rescue medications and when to call emergency services?
- 7.Are there specific safety modifications we should make at home to prevent injuries during 'drop attacks'?
References
References (15)
- 1
Epilepsy with myoclonic-atonic seizures: genetic aetiologies, outcomes and prognostic indicators.
Pellacani S, Balestrini S, Fino E, et al.
Brain communications 2026; (8(1)):fcaf507 doi:10.1093/braincomms/fcaf507.
PMID: 41523187 - 2
Population-based study of rare epilepsy incidence in a US urban population.
Barbour K, Tian N, Yozawitz EG, et al.
Epilepsia 2024; (65(8)):2341-2353 doi:10.1111/epi.18029.
PMID: 38795333 - 3
Epilepsy with myoclonic-atonic seizures, also known as Doose syndrome: Modification of the diagnostic criteria.
Oguni H
European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society 2022; (36()):37-50 doi:10.1016/j.ejpn.2021.11.009.
PMID: 34883415 - 4
Results of an international Delphi consensus in epilepsy with myoclonic atonic seizures/ Doose syndrome.
Joshi C, Nickels K, Demarest S, et al.
Seizure 2021; (85()):12-18 doi:10.1016/j.seizure.2020.11.017.
PMID: 33383403 - 5
Epilepsy with myoclonic-atonic seizures (Doose syndrome): Clarification of diagnosis and treatment options through a large retrospective multicenter cohort.
Nickels K, Kossoff EH, Eschbach K, Joshi C
Epilepsia 2021; (62(1)):120-127 doi:10.1111/epi.16752.
PMID: 33190223 - 6
International League Against Epilepsy classification and definition of epilepsy syndromes with onset in childhood: Position paper by the ILAE Task Force on Nosology and Definitions.
Specchio N, Wirrell EC, Scheffer IE, et al.
Epilepsia 2022; (63(6)):1398-1442 doi:10.1111/epi.17241.
PMID: 35503717 - 7
Epilepsy with myoclonic-atonic seizures: a comprehensive review with emphasis on current and emerging pharmacotherapies.
Samanta D
Expert review of neurotherapeutics 2026; 1-15 doi:10.1080/14737175.2026.2735961.
PMID: 42762175 - 8
A case of epilepsy with myoclonic atonic seizures caused by SLC6A1 gene mutation due to balanced chromosomal translocation.
Mori T, Sakamoto M, Tayama T, et al.
Brain & development 2023; (45(7)):395-400 doi:10.1016/j.braindev.2023.03.001.
PMID: 36966012 - 9
Dynamic thalamo-cortical perfusion changes in myoclonic-atonic seizures captured by ictal technetium-99m ethyl cysteinate dimer single-photon emission computed tomography: A case report.
Matsuura R, Hamano SI, Oba A, et al.
Brain & development 2026; (48(3)):104537 doi:10.1016/j.braindev.2026.104537.
PMID: 42019159 - 10
Parents'/caregivers' fears and concerns about their child's epilepsy: A scoping review.
Carter B, Cook G, Bray L, et al.
PloS one 2022; (17(9)):e0274001 doi:10.1371/journal.pone.0274001.
PMID: 36067199 - 11
Burden and Its Predictors among Caregivers of Patient with Epilepsy.
Pokharel R, Poudel P, Lama S, et al.
Journal of epilepsy research 2020; (10(1)):24-30 doi:10.14581/jer.20005.
PMID: 32983952 - 12
Impact of and research priorities in early onset epilepsy: An investigation of parental concerns.
Lindsay N, Martin J, Adegboye D, et al.
Epilepsy & behavior : E&B 2024; (156()):109794 doi:10.1016/j.yebeh.2024.109794.
PMID: 38733908 - 13
Paradoxical exacerbation of myoclonic-astatic seizures by levetiracetam in myoclonic astatic epilepsy.
Makke Y, Hmaimess G, Nasreddine W, et al.
BMC pediatrics 2015; (15()):6 doi:10.1186/s12887-015-0330-y.
PMID: 25884503 - 14
Efficacy of a ketogenic diet in resistant myoclono-astatic epilepsy: A French multicenter retrospective study.
Stenger E, Schaeffer M, Cances C, et al.
Epilepsy research 2017; (131()):64-69 doi:10.1016/j.eplepsyres.2017.02.005.
PMID: 28273610 - 15
Seizure-related injuries in children and adolescents with epilepsy.
Lagunju IA, Oyinlade AO, Babatunde OD
Epilepsy & behavior : E&B 2016; (54()):131-4.
PMID: 26708062
This page is for informational purposes only and does not constitute medical advice. Your child's pediatric neurologist and care team should guide decisions about EEG interpretation, medication, ketogenic diet, rescue treatment, and safety planning.